Enhancement of the anti-tumor activity of CEA TCB via combination with checkpoint blockade by PD-L1 and interleukin-2 variant immunocytokine

被引：0
|
作者：
Bacac, Marina
Colombetti, Sara
Fahrni, Linda
Fauti, Tanja
Nicolini, Valeria
Sam, Johannes
Papastogiannidis, Petros
Le Clech, Marine
Miot, Xavier
Waldhauer, Inja
Rommel, Karolin
Gerdes, Christian
Klein, Christian
Umana, Pablo
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1594
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
    Meng, Jinyu
    Peng, Jin
    Feng, Jie
    Maurer, Jochen
    Li, Xiao
    Li, Yan
    Yao, Shu
    Chu, Ran
    Pan, Xiyu
    Li, Junting
    Zhang, Ting
    Liu, Lu
    Zhang, Qing
    Yuan, Zeng
    Bu, Hualei
    Song, Kun
    Kong, Beihua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [42] Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
    Jinyu Meng
    Jin Peng
    Jie Feng
    Jochen Maurer
    Xiao Li
    Yan Li
    Shu Yao
    Ran Chu
    Xiyu Pan
    Junting Li
    Ting Zhang
    Lu Liu
    Qing Zhang
    Zeng Yuan
    Hualei Bu
    Kun Song
    Beihua Kong
    Journal of Translational Medicine, 19
  • [43] Dual blockade of PD-L1 and LAG-3 using a bispecific antibody improves anti-tumor immunity
    Ni, Haiqing
    Qiu, Yajing
    Jing, Hua
    Zhang, Pan
    Chen, Bingliang
    Wu, Zhihai
    Zhou, Shuaixiang
    Yu, Michael
    Liu, Junjian
    CANCER RESEARCH, 2020, 80 (16)
  • [44] Overcoming anti-PD-1/PD-L1 immune checkpoint blockade resistance: the role of macrophage, neutrophils and mast cells in the tumor microenvironment
    Kwantwi, Louis Boafo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3077 - 3091
  • [45] Overcoming anti-PD-1/PD-L1 immune checkpoint blockade resistance: the role of macrophage, neutrophils and mast cells in the tumor microenvironment
    Louis Boafo Kwantwi
    Clinical and Experimental Medicine, 2023, 23 : 3077 - 3091
  • [46] Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and exerts synergistic anti-tumor activity with an anti-PD-1 antibody in colon cancer
    Fu, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1843 - 1843
  • [47] Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden
    Gong, Jun
    Patel, Sandip
    Adashek, Jacob J.
    Frishberg, David
    Guan, Michelle
    Placencio-Hickok, Veronica R.
    Gangi, Alexandra
    Gresham, Gillian
    Tuli, Richard
    Chae, Young K.
    Kurzrock, Razelle
    Hendifar, Andrew E.
    JCO PRECISION ONCOLOGY, 2020, 4 : 514 - 519
  • [48] Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade
    Ikebuchi, Ryoyo
    Konnai, Satoru
    Shirai, Tatsuya
    Sunden, Yuji
    Murata, Shiro
    Onuma, Misao
    Ohashi, Kazuhiko
    VETERINARY RESEARCH, 2011, 42
  • [49] Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade
    Ryoyo Ikebuchi
    Satoru Konnai
    Tatsuya Shirai
    Yuji Sunden
    Shiro Murata
    Misao Onuma
    Kazuhiko Ohashi
    Veterinary Research, 42
  • [50] A novel, tumor-targeted immunocytokine comprising an anti-PD-L1 Affimer® fused to IL-15 exhibits potent anti-tumor activity
    Juskaite, Victoria
    Avisetti, Deepa
    Jones, David H.
    Sobri, Ahmad
    Billenness, Gregory
    Buist, Hanna
    Tong, Tik Nga
    Yahya, Norhakim
    McLaughlin, Fiona
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345